AbbVie (ABBV) Equity Ratio (2012 - 2026)

AbbVie (ABBV) has 15 years of Equity Ratio data on file, last reported at 0.05 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.05, down 554.27% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.05 (down 554.27% YoY), and the FY2025 annual result was 0.02, down 198.08% from the prior year.
• Equity Ratio slipped to 0.05 in Q1 2026 per ABBV's latest filing, from 0.02 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.12 in Q4 2022 and troughed at 0.05 in Q1 2026.
• A 5-year average of 0.05 and a median of 0.05 in 2024 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2022 and 2026: Equity Ratio gained 24.84% in 2022, then tumbled 554.27% in 2026.
• A 5-year view of Equity Ratio shows it stood at 0.12 in 2022, then tumbled by 38.03% to 0.08 in 2023, then tumbled by 67.75% to 0.02 in 2024, then slumped by 198.08% to 0.02 in 2025, then slumped by 99.81% to 0.05 in 2026.
• Business Quant data shows ABBV's Equity Ratio at 0.05 in Q1 2026, 0.02 in Q4 2025, and 0.02 in Q3 2025.